What is the appropriate dose of subcutaneous ampicillin and of Unasyn (ampicillin‑sulbactam)?

Dosing of Ampicillin and Unasyn (Ampicillin-Sulbactam)

For adults with normal renal function, administer Unasyn 1.5-3 g IV every 6 hours (maximum sulbactam 4 g/day), with each dose infused over 10-15 minutes or diluted in 50-100 mL over 15-30 minutes. 1

Adult Dosing

Standard Intravenous Dosing

• Unasyn (ampicillin-sulbactam): 1.5 g (1 g ampicillin + 0.5 g sulbactam) to 3 g (2 g ampicillin + 1 g sulbactam) IV every 6 hours 1
• The total sulbactam dose must not exceed 4 g per day 1
• Administer by slow IV injection over at least 10-15 minutes, or as IV infusion in 50-100 mL compatible diluent over 15-30 minutes 1

Ampicillin Alone (when used without sulbactam)

• 200 mg/kg/day divided every 6 hours for complicated intra-abdominal infections 2
• For endocarditis: 12 g/day (maximum adult dose) divided every 4-6 hours 3

Renal Impairment Adjustments

Critical caveat: Both ampicillin and sulbactam are renally eliminated with similar kinetics, so their ratio remains constant regardless of renal function 1

• CrCl ≥30 mL/min: 1.5-3 g every 6-8 hours 1
• CrCl 15-29 mL/min: 1.5-3 g every 12 hours 1
• CrCl 5-14 mL/min: 1.5-3 g every 24 hours 1

Pediatric Dosing

Children ≥1 Year Old

• Unasyn: 300 mg/kg/day (total ampicillin + sulbactam content) IV divided every 6 hours 1
  • This corresponds to 200 mg ampicillin/100 mg sulbactam per kg per day 1
  • Children ≥40 kg: Use adult dosing (maximum sulbactam 4 g/day) 1

Ampicillin Alone in Pediatrics

• Complicated intra-abdominal infections: 200 mg/kg/day divided every 6 hours 2
• Endocarditis: 200-300 mg/kg/day divided every 4-6 hours (maximum 12 g/day) 3

Neonatal Dosing (Ampicillin)

• ≤7 days old and ≤2000 g: 50 mg/kg/day divided every 12 hours 4
• ≤7 days old and >2000 g: 75 mg/kg/day divided every 8 hours 4
• >7 days old and >2000 g: 100 mg/kg/day divided every 6 hours 4

Important Clinical Considerations

Duration of Therapy

• IV therapy should not routinely exceed 14 days 1
• Most pediatric patients in clinical trials transitioned to oral antimicrobials after initial IV Unasyn 1

Subcutaneous Administration

Subcutaneous administration is NOT recommended or approved. The question mentions "subcutaneous ampicillin," but this route lacks FDA approval and guideline support. Recent pharmacokinetic data shows that even with IV administration, tissue penetration to subcutaneous and muscle compartments is adequate, with free drug AUC in subcutis reaching 80 mg/L × h for ampicillin 5. There is no clinical rationale for subcutaneous dosing.

Pharmacokinetic/Pharmacodynamic Targets

• Ampicillin requires 50% fT>MIC for moderate infections and 70% fT>MIC for severe infections 5
• Standard three-times-daily dosing may provide suboptimal target attainment at MICs ≥4 mg/L 5
• For surgical prophylaxis, redosing every 4 hours (not the previously recommended 2 hours) is adequate for most patients 6

Common Pitfalls

1. Exceeding maximum sulbactam dose: Always verify total daily sulbactam does not exceed 4 g 1
2. Inadequate renal dose adjustment: Both components require identical dose reduction in renal impairment 1
3. Insufficient infusion time: Rapid bolus increases adverse effects; maintain 10-15 minute minimum infusion 1
4. Overlooking tissue penetration: Ampicillin/sulbactam achieves therapeutic concentrations in colonic wall (68.8 μg/g) and surgical site tissues approximately 39 minutes post-infusion with high-dose regimens 7